Transfusion Trigger After Operations in High Cardiac Risk Patients

NACompletedINTERVENTIONAL
Enrollment

1,424

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

June 2, 2023

Study Completion Date

March 2, 2024

Conditions
Myocardial InfarctionCoronary RevascularizationAcute Renal Failure
Interventions
PROCEDURE

Blood Transfusion

Blood Transfusion

Trial Locations (16)

14215

VA Western New York Healthcare System, Buffalo, NY, Buffalo

15240

VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh

28805

Asheville VA Medical Center, Asheville, NC, Asheville

32608

North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville

33612

James A. Haley Veterans' Hospital, Tampa, FL, Tampa

44106

Louis Stokes VA Medical Center, Cleveland, OH, Cleveland

55417

Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis

75216

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas

90822

VA Long Beach Healthcare System, Long Beach, CA, Long Beach

92357

VA Loma Linda Healthcare System, Loma Linda, CA, Loma Linda

94121

San Francisco VA Medical Center, San Francisco, CA, San Francisco

97239

VA Portland Health Care System, Portland, OR, Portland

98108

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

72205-5484

Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR, Little Rock

94304-1290

VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto

77030-4211

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT03229941 - Transfusion Trigger After Operations in High Cardiac Risk Patients | Biotech Hunter | Biotech Hunter